 Anna Furniss
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 12 | 2025 | 1381 | 0.790 |
Why?
| | Parents | 7 | 2025 | 1347 | 0.520 |
Why?
| | Papillomavirus Vaccines | 4 | 2024 | 238 | 0.520 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2025 | 37 | 0.400 |
Why?
| | Overweight | 5 | 2023 | 558 | 0.400 |
Why?
| | Klinefelter Syndrome | 2 | 2025 | 65 | 0.390 |
Why?
| | Turner Syndrome | 2 | 2023 | 54 | 0.390 |
Why?
| | Neurodevelopmental Disorders | 3 | 2025 | 181 | 0.370 |
Why?
| | Mental Disorders | 3 | 2025 | 1077 | 0.340 |
Why?
| | Transgender Persons | 2 | 2024 | 186 | 0.330 |
Why?
| | Reminder Systems | 3 | 2016 | 169 | 0.320 |
Why?
| | Text Messaging | 3 | 2016 | 157 | 0.310 |
Why?
| | Safety-net Providers | 2 | 2021 | 119 | 0.300 |
Why?
| | Papillomavirus Infections | 3 | 2024 | 325 | 0.280 |
Why?
| | Weight Loss | 3 | 2017 | 787 | 0.250 |
Why?
| | Health Surveys | 3 | 2025 | 514 | 0.250 |
Why?
| | Anxiety | 2 | 2025 | 1035 | 0.240 |
Why?
| | Rural Health Services | 2 | 2024 | 128 | 0.240 |
Why?
| | Weight Reduction Programs | 2 | 2017 | 117 | 0.230 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 23 | 0.230 |
Why?
| | Rural Population | 3 | 2024 | 563 | 0.220 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 11 | 0.220 |
Why?
| | Hypertension | 3 | 2022 | 1295 | 0.220 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 52 | 0.220 |
Why?
| | Trisomy | 1 | 2025 | 80 | 0.220 |
Why?
| | Obesity | 5 | 2023 | 2992 | 0.220 |
Why?
| | Healthcare Disparities | 3 | 2024 | 654 | 0.220 |
Why?
| | Female | 36 | 2025 | 73304 | 0.220 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2024 | 100 | 0.220 |
Why?
| | Adolescent | 18 | 2025 | 21513 | 0.220 |
Why?
| | Urban Population | 2 | 2024 | 479 | 0.210 |
Why?
| | Colorado | 9 | 2025 | 4565 | 0.200 |
Why?
| | Food Assistance | 1 | 2023 | 30 | 0.200 |
Why?
| | Postpartum Period | 2 | 2023 | 340 | 0.200 |
Why?
| | Child | 16 | 2025 | 21935 | 0.190 |
Why?
| | Genetic Linkage | 2 | 2022 | 297 | 0.190 |
Why?
| | Dental Caries | 1 | 2023 | 155 | 0.190 |
Why?
| | Cardiovascular Diseases | 3 | 2025 | 2111 | 0.180 |
Why?
| | Electronic Health Records | 3 | 2025 | 1069 | 0.180 |
Why?
| | Physicians, Primary Care | 1 | 2024 | 236 | 0.180 |
Why?
| | Gender Dysphoria | 1 | 2021 | 19 | 0.180 |
Why?
| | Humans | 42 | 2025 | 137585 | 0.180 |
Why?
| | Disorders of Sex Development | 1 | 2021 | 39 | 0.180 |
Why?
| | Male | 27 | 2025 | 67762 | 0.170 |
Why?
| | Mood Disorders | 1 | 2021 | 133 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2022 | 176 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2024 | 1329 | 0.160 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1313 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2023 | 956 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 315 | 0.150 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2019 | 36 | 0.150 |
Why?
| | Case-Control Studies | 5 | 2025 | 3556 | 0.150 |
Why?
| | Communication | 1 | 2025 | 879 | 0.150 |
Why?
| | Logistic Models | 5 | 2021 | 2074 | 0.150 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 34 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 91 | 0.140 |
Why?
| | Osteoprotegerin | 1 | 2017 | 24 | 0.140 |
Why?
| | Precision Medicine | 1 | 2022 | 429 | 0.140 |
Why?
| | Exome | 1 | 2019 | 231 | 0.140 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1431 | 0.140 |
Why?
| | Cardiologists | 1 | 2017 | 45 | 0.140 |
Why?
| | Organizations, Nonprofit | 1 | 2017 | 17 | 0.140 |
Why?
| | Adult | 16 | 2025 | 37929 | 0.140 |
Why?
| | Birth Order | 1 | 2017 | 14 | 0.140 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 19 | 0.140 |
Why?
| | Qualitative Research | 1 | 2024 | 1386 | 0.130 |
Why?
| | Infant | 8 | 2025 | 9465 | 0.130 |
Why?
| | United States | 11 | 2025 | 14841 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 406 | 0.130 |
Why?
| | Population Density | 1 | 2017 | 95 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2018 | 205 | 0.130 |
Why?
| | Health Promotion | 3 | 2023 | 741 | 0.130 |
Why?
| | Hearing Tests | 1 | 2017 | 47 | 0.130 |
Why?
| | Parenting | 1 | 2020 | 310 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1171 | 0.130 |
Why?
| | Genome, Human | 1 | 2019 | 425 | 0.130 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5472 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 697 | 0.120 |
Why?
| | Young Adult | 9 | 2025 | 13209 | 0.120 |
Why?
| | Renal Dialysis | 3 | 2009 | 435 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 11074 | 0.120 |
Why?
| | Depression | 1 | 2025 | 1397 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 169 | 0.120 |
Why?
| | Blood Pressure | 2 | 2022 | 1786 | 0.120 |
Why?
| | Aftercare | 1 | 2017 | 208 | 0.120 |
Why?
| | Influenza, Human | 1 | 2021 | 622 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 539 | 0.120 |
Why?
| | Down Syndrome | 1 | 2021 | 496 | 0.110 |
Why?
| | Adolescent Health Services | 1 | 2015 | 71 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 322 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.110 |
Why?
| | Odds Ratio | 3 | 2021 | 1070 | 0.110 |
Why?
| | Middle Aged | 14 | 2025 | 33479 | 0.110 |
Why?
| | Infant, Newborn | 6 | 2023 | 6079 | 0.110 |
Why?
| | Hearing Loss | 1 | 2017 | 221 | 0.110 |
Why?
| | Genetic Variation | 1 | 2019 | 991 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 376 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4149 | 0.100 |
Why?
| | Age of Onset | 2 | 2025 | 518 | 0.100 |
Why?
| | Prediabetic State | 1 | 2016 | 253 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2069 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 1002 | 0.100 |
Why?
| | Risk Assessment | 1 | 2021 | 3457 | 0.090 |
Why?
| | Kidney Failure, Chronic | 2 | 2009 | 570 | 0.090 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2024 | 212 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 581 | 0.090 |
Why?
| | Poverty | 3 | 2023 | 521 | 0.090 |
Why?
| | Aged | 9 | 2025 | 23961 | 0.080 |
Why?
| | Urban Health Services | 2 | 2021 | 63 | 0.080 |
Why?
| | Propensity Score | 2 | 2021 | 294 | 0.080 |
Why?
| | Estradiol | 2 | 2023 | 521 | 0.080 |
Why?
| | Prevalence | 3 | 2025 | 2734 | 0.080 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5778 | 0.080 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2009 | 18 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 91 | 0.070 |
Why?
| | Retrospective Studies | 7 | 2021 | 15657 | 0.070 |
Why?
| | Risk Factors | 5 | 2021 | 10388 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2253 | 0.060 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 103 | 0.060 |
Why?
| | Minority Groups | 2 | 2018 | 266 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 22 | 0.060 |
Why?
| | Time Factors | 4 | 2018 | 6828 | 0.060 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 16 | 0.060 |
Why?
| | Guatemala | 2 | 2016 | 327 | 0.060 |
Why?
| | Washington | 1 | 2025 | 156 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 73 | 0.060 |
Why?
| | Sex Chromosome Aberrations | 1 | 2025 | 64 | 0.060 |
Why?
| | Hospitals | 2 | 2021 | 691 | 0.060 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 68 | 0.060 |
Why?
| | Muscular Atrophy | 1 | 2005 | 86 | 0.060 |
Why?
| | Heart Failure | 1 | 2017 | 2236 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2007 | 286 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5131 | 0.050 |
Why?
| | Cohort Studies | 3 | 2022 | 5742 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 2 | 2022 | 806 | 0.050 |
Why?
| | Dental Hygienists | 1 | 2023 | 11 | 0.050 |
Why?
| | Motivational Interviewing | 1 | 2025 | 107 | 0.050 |
Why?
| | Smoking | 2 | 2024 | 1627 | 0.050 |
Why?
| | Neuroglia | 1 | 2024 | 173 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2005 | 188 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 8 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2024 | 82 | 0.050 |
Why?
| | Cigarette Smoking | 1 | 2024 | 101 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7635 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2024 | 786 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 160 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 849 | 0.040 |
Why?
| | Lower Extremity | 1 | 2005 | 427 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 718 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 144 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 316 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1622 | 0.040 |
Why?
| | Influenza Vaccines | 1 | 2024 | 539 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 6 | 0.040 |
Why?
| | Suicidal Ideation | 1 | 2024 | 529 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 409 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 53 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 263 | 0.040 |
Why?
| | Quality of Life | 2 | 2007 | 2892 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 259 | 0.040 |
Why?
| | Mentors | 1 | 2020 | 202 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 220 | 0.040 |
Why?
| | Health Personnel | 1 | 2024 | 710 | 0.040 |
Why?
| | Mississippi | 1 | 2017 | 21 | 0.040 |
Why?
| | Hospitalization | 2 | 2024 | 2199 | 0.040 |
Why?
| | Nuclear Family | 1 | 2018 | 54 | 0.040 |
Why?
| | Patient Care Team | 1 | 2023 | 631 | 0.040 |
Why?
| | Mastectomy | 1 | 2018 | 137 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1710 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 389 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 762 | 0.030 |
Why?
| | Alcoholism | 1 | 2024 | 807 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 6763 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2844 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2024 | 828 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 230 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 488 | 0.030 |
Why?
| | Emigration and Immigration | 1 | 2017 | 46 | 0.030 |
Why?
| | Maternal Age | 1 | 2017 | 129 | 0.030 |
Why?
| | Suicide | 1 | 2024 | 656 | 0.030 |
Why?
| | Pediatricians | 1 | 2018 | 129 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 986 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 229 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 375 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 163 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 25 | 0.030 |
Why?
| | Peru | 1 | 2016 | 58 | 0.030 |
Why?
| | Income | 1 | 2017 | 202 | 0.030 |
Why?
| | Haemophilus Vaccines | 1 | 2016 | 30 | 0.030 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2016 | 42 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 227 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1704 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 46 | 0.030 |
Why?
| | Hepatitis B Vaccines | 1 | 2016 | 45 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1357 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 73 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2016 | 89 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 411 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1590 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 76 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1639 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3196 | 0.030 |
Why?
| | Prognosis | 3 | 2009 | 4030 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1724 | 0.030 |
Why?
| | Insurance, Health | 1 | 2017 | 283 | 0.030 |
Why?
| | Educational Status | 1 | 2017 | 470 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 642 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1389 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1864 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 197 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 612 | 0.030 |
Why?
| | Women's Health | 1 | 2017 | 372 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 534 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 2189 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1289 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1509 | 0.030 |
Why?
| | Immunization Programs | 1 | 2016 | 213 | 0.030 |
Why?
| | Primary Health Care | 1 | 2024 | 1738 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2018 | 485 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2426 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 435 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2017 | 546 | 0.020 |
Why?
| | Body Mass Index | 2 | 2016 | 2389 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2017 | 556 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 877 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 788 | 0.020 |
Why?
| | Vascular Stiffness | 1 | 2017 | 494 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 2071 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 898 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2057 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 900 | 0.020 |
Why?
| | Cognition | 1 | 2018 | 1153 | 0.020 |
Why?
| | Mothers | 1 | 2016 | 754 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1587 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 329 | 0.020 |
Why?
| | Japan | 1 | 2007 | 115 | 0.020 |
Why?
| | Europe | 1 | 2007 | 414 | 0.020 |
Why?
| | Electric Impedance | 1 | 2005 | 107 | 0.010 |
Why?
| | Survival Rate | 1 | 2009 | 1972 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 408 | 0.010 |
Why?
| | Survival Analysis | 1 | 2006 | 1325 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2031 | 0.010 |
Why?
| | Gait | 1 | 2005 | 296 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10811 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 684 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 635 | 0.010 |
Why?
| | Walking | 1 | 2005 | 529 | 0.010 |
Why?
|
|
Furniss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|